Department of Public Health and Hygiene, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
J Gerontol A Biol Sci Med Sci. 2012 Feb;67(2):126-34. doi: 10.1093/gerona/glr189. Epub 2011 Oct 20.
The study aim was to test whether the metabolic syndrome or its components predicted cognitive decline among persons aged 80 years and older (mean 85.0 years). Participants were members of the "Keys to Optimal Cognitive Aging Project," a prospective cohort study in Okinawa, Japan. Metabolic syndrome was assessed at baseline. Cognitive functions were assessed annually for up to 3 years. One hundred and forty-eight participants completed at least one follow-up with 101 participating in all three assessments and 47 participating in two of the three assessments. The mean and median duration of follow-up were 1.8 and 2 years, respectively. Metabolic syndrome and four components were not associated with decline in global and executive cognitive functions. However, high glycosylated hemoglobin was associated with decline in memory function at the second follow-up. Our study supports accumulating evidence that the positive association between metabolic syndrome and cognitive function might not hold for the oldest old.
本研究旨在测试代谢综合征或其组成部分是否可预测 80 岁及以上人群(平均 85.0 岁)的认知能力下降。参与者为日本冲绳“最佳认知老化计划”的前瞻性队列研究的成员。在基线时评估代谢综合征。认知功能每年评估一次,最长可达 3 年。148 名参与者完成了至少一次随访,其中 101 名参与者参加了所有三次评估,47 名参与者参加了其中两次评估。随访的平均和中位数时间分别为 1.8 年和 2 年。代谢综合征及其四个组成部分与整体和执行认知功能下降无关。然而,高糖化血红蛋白与第二次随访时的记忆功能下降有关。我们的研究支持越来越多的证据表明,代谢综合征与认知功能之间的正相关关系可能不适用于最年长的老年人。